Group B streptococcus in the antenatal clinic and in the delivery room: A matter of systematic attitude;Le streptocoque du groupe B en clinique anténatale et en salle de travail: Un problème d'attitude systématique

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 2, 2005, Pages 115-127

  Lorquet, S ^a   Melin, P ^a   Minon, J M ^a   Carpentier, M ^a   Gerday, C ^a   Rigo, J ^a   Foidart, J M ^a  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Clinical practice; Evaluation; Group B streptococci (GBS); Guidelines; Prevention

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ERYTHROMYCIN;

ALGORITHM; ANTIBIOTIC PROPHYLAXIS; ANTIGEN DETECTION; ARTICLE; ATTITUDE; BACTERIAL COLONIZATION; CLINICAL PRACTICE; DELIVERY ROOM; EVALUATION; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LABOR; MAJOR CLINICAL STUDY; NEWBORN INFECTION; PRACTICE GUIDELINE; PRENATAL CARE; RECTUM; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNIVERSITY HOSPITAL; VAGINA SMEAR;

EID: 17144410382     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82703-6     Document Type: Article

References (32)

1. Ducoffre G. Surveillance des maladies infectieuses par un réseau de laboratoires de microbiologie 1998 Tendances épidémiologiques 1983-1997, 1999; Septicémies et méningites néonatales.
2. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665-9.
3. Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ 1993; 149: 1659-65.
4. Easmon CS, Hastings MJ, Deeley J, Bloxham B, Rivers RP, Marwood R. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. Br J Obstet Gynaecol 1983; 90: 633-5.
5. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morbid Mortal Wkly Rep 1996; 45: 1-24.
6. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns [opinion 173]. Washington, D.C: American College of Obstetricians and Gynecologists, 1996.
7. Gotoff SP, Boyer K. Combined selctive chemoprophylais of early onset neonatal group B streptococcal disease (GBS EOD). Adv Exp Med Biol 1997; 418: 267-8.
8. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992; 90: 775-8.
9. Group B streptococcal infections in pregnancy. ACOG Technical Bull 1992; 170: 1-5.
10. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002; 347: 233-9.
11. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gottoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. Predictive value of prenatal cultures. J Infect Dis 1983; 148: 802-9.
12. Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001; 184: 1204-10.
13. Main EK, Slagle T. Prevention of early-onset invasive group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. Am J Obstet Gynecol 2000; 182: 1344-54.
14. Lieu TA, Mohle-Boetani JC, Ray GT, Ackerson LM, Walton DL. Neonatal group B streptococcal infection in a managed care population. Perinatal group B Streptococcal Infection Study Group. Obstet Gynecol 1998; 92: 21-7.
15. ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2002; 100: 1405-12.
16. Davies HD, Adair CE, Schuchat A, Low DE, Sauve RS, McGeer A. Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ 2001; 164: 479-85.
17. Agence nationale d'Accréditation et d'Evaluation en Santé. Service recommandations et références professionnelles. Diagnostic et traitement curatif de l'infection bactérienne précoce du nouveau-né. ANAES 2002.
18. Wendel GD Jr, Leveno KJ, Sanchez PJ, Jackson GL, McIntire DD, Siegel JD. Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol. Am J Obstet Gynecol 2002; 186: 618-26.
19. Melin P, Schmitz M, Tsobo C, Hayette MP, De Mol P. Test rapide de dépistage intrapartum et cultures prénatales pour l'identification des parturientes colonisées par GBS: une étude prospective. Évaluation des techniques de dépistage du GBS-Centre de Référence des GBS - Projet de médecine préventive en Communauté Française en 1999-2000, novembre 2000: 1-6.
20. Regan JA, Klebanoff MA, Nugent RP, Escenbach DA, Blackwelder WC, Lou Y et al. Colonisation with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol 1996; 174: 1354-60.
21. Armer T, Clark P, duff P, Saravnos K. Rapid intrapartum detection of group B streptococcal colonisation with an enzyme immunoassay. Am J Obstet Gynecol 1993; 168: 39-43.
22. Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES), Service recommandations et références professionnelles. Prévention anténatale du risque infectieux bactérien néonatal précoce. ANAES 2001.
23. Roy Niox Château F. Prȩvalence du portage du streptocoque du groupe B dans la population tourangelle. Étude prospective sur 1 041 femmes enceintes. Variations et pouvoir pathogène. Tours: Université Franćois-Rabelais; 1996.
24. th Intersciences Conference on Antimicrobial Agents and Chemotherapy (ICAAC), October 2004, Washington, USA, Abstract book, no.G-499.
25. Ferrieri P, Cleary PP, Seeds AE. Epidemiology of group B streptococal carriage in pregnant women and newborn infants. J Med Microbiol 1977; 10: 103-14.
26. De Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998; 91: 112-4.
27. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999; 103: e77.
28. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zagnwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994; 13: 623-9.
29. Melin P, Verschraegen G, Mahieu L, Claeys G, De Mol P. Towards a Belgian consensus for prevention of perinatal group B streptococcal disease. Indian J Med Res 2004; 119 (suppl): 197-200.
30. Bergeron M, Danbing K, Ménard C, Picard F, Gagnon M, Bernier M et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343: 175-9.
31. Philipson EH, Herson V. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: who should be treated? Am J Perinatol 1996; 13: 487-90.
32. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983; 148: 795-801.